Navigation Links
World class to second class? Confronting the risks to US science and innovation
Date:2/7/2012

A Research!America Discussion: "World Class to Second Class? Confronting the Risks to U.S. Science and Innovation"

WHAT: Research!America 2012 National Health Research Foruma unique interactive gathering of top policy makers. This discussion brings together heads of federal agencies for health research, as well as nationally recognized leaders from industry, academia and patient advocacy. Two panels will each be followed by Q&A, exploring the current landscape for medical and health research and strategies for maintaining a robust R&D sector in the United States.

WHEN: Wednesday, March 14, 2012
Noon-3 p.m.
Lunch will be served at noon. Program begins at 12:30 p.m.

WHO: Moderators:

Richard Besser, MD, chief health and medical editor, ABC News
David Leonhardt, Washington bureau chief, The New York Times

Confirmed panelists:

Francis S. Collins, MD, PhD, director, National Institutes of Health
Margaret A. Hamburg, MD, commissioner, Food and Drug Administration
Carolyn M. Clancy, MD, director, Agency for Healthcare Research and Quality
Subra Suresh, MS, ScD, director, National Science Foundation
Thomas R. Frieden, MD, MPH, director, Centers for Disease Control and Prevention
Nancy Brown, chief executive officer, American Heart Association
James Madara, MD, executive vice president and chief executive officer, American Medical Association
Sheri McCoy, MSc, vice chairman of the executive committee and member of the office of the chairman, Johnson & Johnson
Larry Shapiro, MD, executive vice chancellor for medical affairs and dean of the school of medicine, Washington University School of Medicine
Jack Watters, MD, vice president of external medical affairs, Pfizer Inc

WHERE: Ronald Reagan Building and International Trade Center Pavilion Room
1300 Pennsylvania Ave., NW
Washington, DC

RSVP: Suzanne Ffolkes, 571 482 2710 or sffolkes@researchamerica.org


'/>"/>

Contact: Suzanne Ffolkes
sffolkes@researchamerica.org
571-482-2710
Research!America
Source:Eurekalert

Related biology news :

1. BIO-key(R) International To Exhibit at Oracle OpenWorld
2. World leaders in infectious diseases convene to discuss emerging global viruses
3. Researchers document worlds mammals in crisis
4. Complete Genomics launches, becomes worlds first large-scale human genome sequencing company
5. Europe rallies behind nanotechnology to wean world from fossil fuels
6. Smithsonian perspective: Biodiversity in a warmer world
7. Take advantage of reduced pre-registration rates for the IOF World Congress on Osteoporosis
8. World Food Day brings attention to food security around the globe
9. Fitness in a changing world
10. Researchers uncover worlds oldest fossil impression of a flying insect
11. Providing toilets, safe water is top route to reducing world poverty: UN University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... YORK , Feb. 7, 2017 Report Highlights ... The ... should reach $11.4 billion by 2021, growing at a compound ... Includes - An overview of the global markets for synthetic ... 2015, estimates for 2016, and projections of compound annual growth ...
(Date:2/7/2017)... Ind. , Feb. 7, 2017 Zimmer ... leader in musculoskeletal healthcare, will present at the LEERINK ... New York Palace Hotel on Wednesday, February 15, 2017 ... live webcast of the presentation can be accessed at ... replay following the conference via Zimmer Biomet,s Investor Relations ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ... immunotherapies, will host a Key Opinion Leader event to ... an oral and poster presentation at the upcoming 2017 ... The KOL event will be held in-person and via ... EST / 9:00 AM PST at the Lotte New ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017  MIODx ... license for two key immunotherapy technologies from the ... technology provides a method to monitor a patient ... as PD-L1 and CTLA-4.  The second license extends ... a patient is likely to have an immune-related ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... that in a published evaluation of multiple immunoassay-based threat detection technologies by ... Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have ...
(Date:2/23/2017)... Feb. 23, 2017 Aviva Systems Biology ... the acquisition of GenWay Biotech Incorporated, a protein ... and product offering for both the research and ... growth and enhance capabilities for both entities. GenWay,s 18 ... assays will nicely complement ASB,s objective to become ...
Breaking Biology Technology: